// App-Quantinova.ai

: Venous Thromboembolism in Cancer Patients Receiving Immunotherapy

Researchers

Presenter

  • Joanna Roopkumar

Principal Investigators

  • Ann S. Kim

  • Thapa Bicky

  • Brian P. Hobbs

  • Alok A. Khorana

Medical Centers

  • Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

  • Cleveland Clinic, Cleveland, OH

  • Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH

  • Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

  • Deep vein thrombosis

  • Pulmonary embolism

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Pembrolizumab

  • Atezolizumab

  • Durvalumab

  • Ipilimumab

  • Nivolumab

  • Avelumab

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A